Correction: Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2021 Financial Results
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Company reports strong revenue growth of 22%...
Year: 2022
Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults
First novel, nonstimulant option for adults with ADHD in 20 yearsADHD affects an estimated 10 million adults in the U.S.ROCKVILLE,...
Myovant Sciences Announces European Commission Approval for ORGOVYX® (relugolix) for the Treatment of Advanced Hormone-Sensitive Prostate Cancer
ORGOVYX® is the first and only oral androgen deprivation therapy for advanced hormone-sensitive prostate cancer in EuropeMyovant expects to secure...
Aurora Spine Corporation Announces Fourth Quarter and Fiscal 2021 Financial Results
CARLSBAD, Calif, April 29, 2022 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE...
180 Life Sciences and University of Oxford Announce Publication of Positive Phase 2b Dupuytren’s Disease Study Results in The Lancet Rheumatology
The study achieved the primary endpoint of reduction in nodule hardness at 12 months and secondary endpoint of reduction in...
Lotus Reports First-Half Results for Fiscal Year 2022
VANCOUVER, BC / ACCESSWIRE / April 29, 2022 / Lotus Ventures Inc. (CSE:J)(OTC PINK:LTTSF) ("Lotus" or the "Company"), a premium...
Neovasc to Report First Quarter Financial Results on May 12, 2022
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - April 29, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), will report financial...
B-Secur’s EKG Cloud Tech Improves Accuracy in Heart Health Monitoring
FDA-cleared HeartKey® 2.0 launches to power next generation of medical and consumer devices and platforms SAN FRANCISCO--(BUSINESS WIRE)--Global heart health...
HST Pathways Announces Acquisition of Simplify ASC
This acquisition further underscores HST’s longstanding commitment to enhancing ASC technology and delivering improved patient outcomes across the industry. NASHVILLE--(BUSINESS...
Moderna Files to Expand Conditional Marketing Authorization for Its COVID-19 Vaccine to Include Children Six Months to Under Six Years in The European Union
The filing follows the European Medicines Agency's Committee for Medicinal Products for Human Use recent decision to adopt a positive...
Moderna Finalizes Plan for Long-Term Strategic Partnership with The Government of Canada
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses...
CORRECTION: Cloud DX Announces Investor Event to Recap Financials and Q1 Growth
This replaces and corrects a release that ran earlier in the week.KITCHENER, ON / ACCESSWIRE / April 29, 2022 /...
Avinger to Announce First Quarter 2022 Results on May 10
REDWOOD CITY, CA / ACCESSWIRE / April 29, 2022 / Avinger, Inc. (Nasdaq:AVGR), commercial-stage medical device company marketing the first...
Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M
ORLANDO, FL / ACCESSWIRE / April 29, 2022 / Nutriband Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products, today announced...
Dr. Gregg Sturrus’ TEDx Talk(R) Features Halberd’s Extracorporeal Treatment of Neurodegenerative Diseases
JACKSON CENTER, PA / ACCESSWIRE / April 29, 2022 / A key member of Halberd Corporation's (OTC PINK:HALB) Research Team,...
Abeona Therapeutics Announces Presentation at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
NEW YORK and CLEVELAND, April 29, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell...
HEXO Announces Leadership Transition; Company Appoints Charlie Bowman as Chief Executive Officer and Julius Ivancsits as Chief Financial Officer
Scott Cooper Steps Down; Board of Directors Acknowledge Cooper in Stabilizing the Company Bowman and Ivancsits to Lead HEXO’s Continued...
Galecto Reports First Quarter Operating and Financial Results
BOSTON, April 29, 2022 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development...
Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022
REDWOOD CITY, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its first quarter...
Enlivex Announces Full Year 2021 Financial Results, Completion of Development of Frozen Formulation Allocetra™ Ahead of Schedule, and Provides Strategic & Business Updates
Development of frozen formulation Allocetra™, a primary cornerstone of Enlivex’s R&D efforts during the last two years, was successfully completed...